Subscribe to RSS - diabetes

diabetes

FDA approves FreeStyle app

 - 
11/01/2018

ABBOTT PARK, Ill. – The FreeStyle LibreLink app has been approved by the U.S. Food and Drug Administration for the iPhone, according to a press release from Abbott. The app allows user to capture and view real-time glucose levels.

'Smart' technology boosts management

 - 
10/30/2018

Because diabetes patients are so involved in the management of their disease, technology is key to helping them stay healthy.

Ascensia gets ‘seal of approval’ for Contour Next

 - 
09/25/2018

BASEL, Switzerland – The Contour Next BGMS finished top of the list for accuracy, according to the results of a recently published assessment of 18 blood glucose monitoring systems.

Q&A: Ascensia’s Russ Newsome

Health apps should be seamless, predictive
 - 
08/17/2018

PARSIPPANY, N.J. – Ascensia Diabetes Care recently selected the Culinary Coach, a digital solution from U.K.-based Whisk that provides personalized food recommendations to users, as the winner of its Ascensia Diabetes Challenge.

Abbott upgrades FreeStyle Libre

 - 
08/01/2018

ABBOTT PARK, Ill. – The U.S. Food and Drug Administration has approved Abbott’s FreeStyle Libre 14-day Flash Glucose Monitoring System.

Ascensia Diabetes goes toward future

 - 
06/25/2018

PARSIPPANY, N.J. – Ascensia Diabetes Care has upgraded its Contour Diabetes app to help users self-manage their diabetes better by analyzing behavior patterns and suggesting new ones.

CMS changes course on CGM policy

 - 
06/12/2018

WASHINGTON – CMS will allow Medicare beneficiaries to use smart phone technology with their continuous glucose monitors, it announced.

FDA clears Omnipod DASH

 - 
06/06/2018

BILLERICA, Mass. – Insulet Corp. has received clearance from the U.S. Food and Drug Administration for its Omnipod DASH Insulin Management System. The Omnipod DASH features an easy-to-read, touch-screen PDM; user-friendly steps to manage basal rates; and a food library.

ADA: Improve insulin access, affordability

 - 
05/31/2018

ARLINGTON, Va. – The American Diabetes Association on May 24 released a public policy statement outlining both long- and short-term recommendations for improving insulin access and affordability.

Inolife primes ADW to distribute Inojex

 - 
04/17/2018

TORONTO – Inolife R&D has entered into a letter of intent with ADW Diabetes for the distribution of its Inojex, a patented and FDA-cleared needle-free injection device.

Pages